Best Bayesian vancomycin dosing software for hospitals, compared by EHR fit, accuracy and budget
Since the 2020 vancomycin guideline moved hospitals from troughs to AUC, Bayesian dosing software has become a line item in most pharmacy budgets. Here is how the main products compare on the three things that decide the purchase.
8 min read
The Bayesian vancomycin dosing software most US hospitals shortlist is InsightRx Nova, DoseMeRx and PrecisePK. Sentri7 and VigiLanz connect to these tools rather than replacing them. In the only published head-to-head on critically ill patients, PrecisePK was the least biased and InsightRx the easiest to use, and the gaps were modest. EHR integration and pharmacist workflow usually decide the purchase, and no vendor publishes a price.
This is written for the pharmacy director or stewardship pharmacist who has to pick one and defend the budget. Each product is described from its vendor's own pages and from peer-reviewed studies, named inline so you can check them.
Why hospitals are buying dosing software now
The 2020 revised consensus guideline from ASHP, IDSA, PIDS and SIDP (Rybak and colleagues, American Journal of Health-System Pharmacy, 2020) recommends dosing vancomycin for serious MRSA infections to an AUC of 400 to 600 mg·h/L, assuming an MIC of 1 mg/L, and no longer recommends trough-only monitoring. It names Bayesian software as the preferred way to estimate AUC, because it can work from one or two levels drawn at convenient times.
Hospitals can calculate AUC with first-order equations from two levels, and some do it in a spreadsheet. The software earns its license when pharmacy-to-dose volume is high, when pharmacists cover nights from a distance, or when the hospital wants the dose documented in the EHR without re-keying weights, creatinine values and administration times.
Bayesian vancomycin dosing software compared
| Product | EHR integration | Surveillance tie-in | 2018 study finding |
|---|---|---|---|
| InsightRx Nova | Epic Showroom, Oracle Health and MEDITECH, through SMART on FHIR | Says it integrates with leading clinical surveillance tools | Most adaptable, easiest to use, most company support |
| DoseMeRx | Embedded in Epic Hyperspace and Oracle Health (Cerner) PowerChart through SMART on FHIR | Sentri7 and VigiLanz | Accuracy improved with a second level |
| PrecisePK | States it integrates with multiple EHR systems, ask which | Sentri7 | Least biased (median 5.1 percent), harder to use |
| Sentri7 Bayesian dosing | Inside Sentri7, which integrates with the EHR | Is the surveillance platform, uses PrecisePK or DoseMeRx for the math | Not studied separately |
| Two-level equations in a spreadsheet | None, results are typed into the chart | None | Similar or better accuracy than Bayesian tools when two levels are drawn |
The products one by one
InsightRx Nova is the one pharmacists most often describe as pleasant to use, and the 2018 study agreed. The company says it is certified in the Epic Showroom, connects to Oracle Health and MEDITECH through SMART on FHIR, and is used by more than 1,000 hospitals. The company puts implementation at 4 to 8 weeks. It also models aminoglycosides, busulfan, beta-lactams and antifungals, which matters if those are next on your list.
DoseMeRx is the US version of DoseMe, founded in Brisbane and bought by Tabula Rasa HealthCare in 2018. Its integration page lists Epic, Cerner, Sentri7 and VigiLanz, and it runs embedded in Hyperspace and PowerChart. For a hospital that already runs Sentri7 or VigiLanz, that existing connection shortens the project.
PrecisePK, from Healthware, leads on accuracy in the published comparison and also models busulfan, methotrexate, cyclosporine and infliximab. The same study found it harder to use, so plan for training time. Wolters Kluwer lists it, with DoseMeRx, as one of the two dosing engines behind Sentri7 Bayesian dosing.
If you are choosing a surveillance platform at the same time, how Sentri7, VigiLanz and TheraDoc handle precision dosing is covered in Sentri7 vs TheraDoc vs VigiLanz.
Which vancomycin dosing software is most accurate?
In the only published head-to-head, PrecisePK was the least biased, with a median bias of 5.1 percent from a trough alone. Turner and colleagues (Pharmacotherapy, 2018) tested five programs on 19 critically ill patients: accuracy ranged from 0.79 to 1.03 and bias from 5.1 to 21.2 percent. Adding a second level helped DoseMe and InsightRx most.
Two cautions keep that from being the whole answer. Nineteen patients is a small study, and the programs have been updated since. A 2022 review by Chen and colleagues found 12 Bayesian programs and concluded that the population model matters more than the brand: pick one whose models were built on patients like yours. A Cincinnati Children's study published in AJHP in September 2026 showed how much that matters in a NICU, where a pediatric model predicted troughs better than the neonatal one in most groups.
Is Bayesian dosing software worth the cost?
For most acute care hospitals, yes. A cost-benefit analysis by Lee and colleagues (Clinical Microbiology and Infection, 2021) found single-sample Bayesian AUC dosing saved an average of $2,065 per patient encounter against trough dosing, mainly through less acute kidney injury. At a software budget of $100,000 a year, a hospital broke even after 41 patients treated for 48 hours or more.
That break-even point is low enough that a community hospital can clear it, which is why the purchase is rarely about whether, and mostly about which. The real costs to plan for are the EHR integration project, pharmacist training and the time to rewrite the pharmacy-to-dose protocol.
How much does vancomycin dosing software cost?
None of the three vendors publishes a price, so you will get a quote. The published model above assumed $100,000 a year, which is a useful ceiling for a budget request rather than a list price. Ask each vendor for the annual license, the one-time integration fee, whether pricing is per bed or per facility, and which drug models are included or extra.
Ask the surveillance vendor too. If Sentri7 or VigiLanz already runs in your hospital, the dosing engine may come through that contract, and that changes the comparison.
How to choose
Software does not fix a consult queue on its own. If pharmacy-to-dose requests land in a shared inbox, routing them with task assignment software to whichever pharmacist is covering the unit keeps the first level from being drawn hours late.
- Start with your EHR. Epic hospitals can compare Showroom apps directly, Oracle Health hospitals should ask for a PowerChart reference site, and MEDITECH hospitals have the shortest list
- Check your surveillance platform. Sentri7 sites already have a path to PrecisePK and DoseMeRx, and VigiLanz sites to DoseMeRx
- Match the population. A children's hospital or a large NICU should ask for the pediatric and neonatal model validation before anything else
- Count pharmacist time. If consults arrive faster than pharmacists can work them, ease of use beats a few points of bias
- Ask which other drugs are modeled. Aminoglycosides and busulfan often follow vancomycin onto the same platform
Where the antibiogram fits
Dosing software answers how much vancomycin. It does not answer whether vancomycin belongs in the empiric regimen at all, or which gram-negative agent to pair with it. Those questions depend on your own resistance rates: MRSA as a share of Staphylococcus aureus, and how your E. coli, Klebsiella and Pseudomonas isolates respond to cefepime, piperacillin-tazobactam and meropenem on each unit.
That is the cumulative antibiogram, and stewardship teams that are buying dosing software are usually also the ones asking why theirs arrives once a year as a PDF. Antimicrobe builds it from the lab's susceptibility export, following CLSI M39, and ranks empiric options by local susceptibility. The Lab plan is $249 a month; unit cuts such as an ICU table, syndrome groups and quarterly trends are on Stewardship at $749 a month.
How unit tables change empiric choices is covered on ICU antibiogram software, and the full report on hospital antibiogram software. Every plan limit is on the pricing page.
Questions to ask on the demo
- Which population models do you use for adults, obese patients, pediatrics, neonates and patients on dialysis, and where are they validated?
- Show the integration in our EHR version. Who builds it, how long did it take at a hospital our size, and who maintains it after an upgrade?
- Does the dose recommendation document back to the chart automatically?
- What does the annual license include, and what is billed separately?
- Can we export dosing data for our own stewardship reports?
- Can you give us a reference site with our EHR and our bed count?
Related on this site: Sentri7 vs TheraDoc vs VigiLanz, Sentri7 alternatives and competitors, empiric antibiotic therapy by local resistance, antimicrobial stewardship software pricing.